跳至主要内容
临床试验/NL-OMON48362
NL-OMON48362已完成2 期

Effects of sodium lactate infusion in patients with glucose transporter 1 deficiency syndrome (GLUT1DS) - Lactate infusion in GLUT1DS

Radboud Universitair Medisch Centrum0 个研究点目标入组 4 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
4

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • Diagnosed with GLUT1DS and known in our center.
  • Baseline characteristics include a high frequency of clinical seizures and
  • epileptic discharges on EEG.
  • History of trying ketogenic diet with good compliance without beneficial
  • Age > 6 years.
  • Informed consent.

排除标准

  • Additional medical condition or illness that impairs the patient*s ability to
  • participate in the study (for example actual treatment of a malignancy, active
  • infection, poorly controlled diabetes mellitus, hypertension, organ failure,
  • clinically significant haematological or biochemical abnormalities).
  • Elevated serum sodium (> 145 mmol/L).
  • Participation in another interventional study at start of the study or during
  • Presence of known panic disorders or a history of panic attacks.

研究者

相似试验

Effects of sodium lactate infusion in patients with... | 临床试验